<?xml version="1.0"?>
<Articles JournalTitle="Frontiers in Emergency Medicine">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Frontiers in Emergency Medicine</JournalTitle>
      <Issn>2717-3593</Issn>
      <Volume>6</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2022</Year>
        <Month>06</Month>
        <Day>23</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Herpes simplex encephalitis after receiving COVID-19 vaccine; a case report</title>
    <FirstPage>e56</FirstPage>
    <LastPage>e56</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Ebadi</LastName>
        <affiliation locale="en_US">Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fereshteh</FirstName>
        <LastName>Ghadiri</LastName>
        <affiliation locale="en_US">Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Elnaz</FirstName>
        <LastName>Asadollahzade</LastName>
        <affiliation locale="en_US">Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abdorreza</FirstName>
        <LastName>Naser Moghadasi</LastName>
        <affiliation locale="en_US">Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>06</Month>
        <Day>18</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>06</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Shortly after the onset of the coronavirus pandemic, different vaccines were developed to combat it. The vaccines had different mechanisms and triggered cellular and humoral immune responses against the virus. In addition to their positive effects, various side effects have been reported for them. They rarely cause severe complications. They can also rarely trigger latent infections. The present case report presents a patient who developed herpes simplex encephalitis after receiving the second dose of the Covaxin (BBV152).</abstract>
    <web_url>https://fem.tums.ac.ir/index.php/fem/article/view/1025</web_url>
    <pdf_url>https://fem.tums.ac.ir/index.php/fem/article/download/1025/412</pdf_url>
  </Article>
</Articles>
